Dr Reddy's Q2 Earnings: Here's what to expect

Pharma major Dr Reddy's Laboratories is all set to announce its quarterly results today. Here's what to expect from the company:

Revenue growth of around 8 percent is expected.

Margins are expected to come in flattish on a year-on-year (YoY) basis at around 22 percent.

Profit is likely to be at around Rs 723 crore which would be significant as compared to the Rs 503 crore in the same period last quarter.

The numbers will be supported by the sale of migraine drugs which took place. The deal closed in August in which the company sold around two migraine drugs worth $110 million to Upsher-Smith.

Besides, the US market is also expected to drive growth.

India is expected to continue the momentum.

Active ingredients business is expected to bounce back after what was around 15-16 percent fall last quarter.